On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
John Field has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool and is Director of Research of the Roy Castle Lung Cancer Research Programme. He is the Chief Investigator for the UK Lung Cancer Screening Trial (UKLS). He is a previous recipient of the IASLC Joseph Cullen Award at the World Conference on Lung Cancer in recognition of lifetime scientific achievements in lung cancer prevention research.
He is the principle investigator of the Liverpool Lung Project, a molecular- epidemiological study into the early detection of lung cancer, which has now recruited 13,000 participants. The UKLS Trial and the Liverpool Lung Project form part of the National Cancer Research Institute Lung Cancer portfolio. He has contributed to the lung cancer genetic susceptibility ‘Lung Oncoarray’ project and is heavily involved in the identification of molecular markers in lung and head & neck cancers.
In this seminar, Professor Field will discuss UKLS, the first lung cancer screening trial to take place in the UK.
